The QualityStocks Daily Friday, January 25th, 2019

Today's Top 3 StockMarketWatch

NetworkNewsWire (CYBF) +99.74%

QualityStocks (CLWD) +36.05%

BUYINS.NET (RAND) +32.74%

The QualityStocks Daily Stock List

Data Storage Corp. (DTST)

Real Pennies, Epic Stock Picks, TopPennyStockMovers, Wolf of Penny Stocks, Actual Gains, PennyStockRumors, Penny Pick Finders, RockingPennyStocks, Buzz Stocks, Stock Guru, Planet Penny Stocks, PennyStocks24, PricelessPennyStocks, Stock Twiter, SecretStockPromo, Stock Onion, EpicVIP Group, Penny Picks, PennyStockProphet, Bull Trends, Information Solutions Group, StockMister, Penny Dreamers, AlphaPennyStock, and Investor News Source reported earlier on Data Storage Corp. (DTST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Data Storage Corp. provides cloud-based technology solutions. The Company provides hardware, software-as-a-service (SaaS), managed IT (Information Technology) services, installation, and maintenance, focused on compliance, message archiving, analytics, disaster recovery, and business continuity. Message Logic is a business unit of the Company. Data Storage is based in Melville, New York. A Cloud Services Provider, the Company lists on the OTCQB.

Data Storage has acquired ABC Services and ABC Services II (a 25-year provider of IBM equipment, IAAS, managed and professional services) including the remaining 50 percent ownership of Secure Infrastructure and Services. With this acquisition, Data Storage expands its current solutions.

Data Storage provides its solutions and services through leveraging leading technologies. These include virtualization, cloud computing, as well as cloud storage. The Company created Nexxis, Inc. This subsidiary focuses on the development of next-generation voice and data services intended to help companies speed up their communications, increase revenue, and lessen costs.

Data Storage’s solutions include offsite data protection and recovery services, High Availability (HA) replication services, email compliance solutions for e-discovery, continuous data protection, data de-duplication, virtualized system recovery, and telecommunications recovery services. The Company’s Message Logic business unit delivers regulatory compliant email archiving and analytics to enterprises globally.

Message Logic’s MLArchiver provides a solution uniting archiving, records management, eDiscovery, and analytics to deliver a new level of advanced capabilities. Furthermore, the Company’s Secure Infrastructure & Services centers on providing infrastructure as a service (IAAS). It specializes in power systems, iseries and AS400 users.

This month, Data Storage announced the addition of its newest data center located in North Carolina. The new data center has the latest enterprise technology. Its focus is on delivering Infrastructure as a Service (IaaS), Disaster Recovery as a Service (DRaaS), and High Availability as a Service (HAaaS). The data center’s technology is reserved for IBM Power systems running IBM i, AIX and Linux, and also Intel systems running Microsoft Windows virtual environments.

Data Storage Corp. (DTST), closed Friday's trading session at $0.16875, up 7.14%, on 1,150 volume with 1 trade. The average volume for the last 3 months is 9,547 and the stock's 52-week low/high is $0.0806/$0.695.

chart

GT Biopharma, Inc. (GTBP)

NetworkNewsWire, Stockhouse, Infront Analytics, MarketWatch, The Street, Stockopedia, PR Newswire, GuruFocus, InvestorsHub, Insider Financial, Market Screener, OTC Markets, Morningstar, YCharts, Street Insider, and Simply Wall St reported previously on GT Biopharma, Inc. (GTBP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

GT Biopharma, Inc. focuses on unique drugs for the treatment of cancer and CNS diseases (Neurology and Pain), along with other unmet medical needs. The Company’s lead oncology drug candidate is OXS-1550 (DT2219ARL). It owns the worldwide rights to commercialize OXS-1550. GT Biopharma is based in Tampa, Florida and the Company lists on the OTC Markets’ OTCQB.

GT Biopharma concentrates on innovative treatments based on its proprietary NK-engager and Bispecific Antibody Drug Conjugate platforms. The Company is targeting multiple myeloma, triple-negative breast cancer, non-Hodgkin’s lymphoma, and more. It is doing so with highly potent biopharmaceutical drugs designed for targeted therapy. Its current CNS pipeline products include treatment for neuropathic pain, the symptoms of myasthenia gravis, and motion sickness. 

GT Biopharma’s CNS platform focuses on acquiring or discovering and patenting late-stage, de-risked, and close-to-market improved treatments for CNS diseases. Furthermore, the CNS platform focuses on guiding the products through the Food and Drug Administration (FDA) approval process to the NDA.

OXS-1550 is an ADC (Antibody Drug Conjugate) drug. What makes OXS-1550 (DT2219ARL) different from other treatments, such as chemotherapy, is that the design of it is to specifically target and kill cancer cells while reducing damage to normal tissues. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. When OXS-1550 binds to cancer cells, the cancer cells internalize the drug and are killed due to the action of cytotoxic payload.

Researchers at the University of Minnesota Masonic Cancer Center developed the OXS-3550 TriKE technology. This targeted immunotherapy directs immune cells to kill cancer cells while decreasing drug-related toxicity.

Last month, GT Biopharma announced that it presented data demonstrating the effectiveness of its Tri-specific Killer Engagers (TriKEs) for the treatment of acute myeloid leukemia (AML) presented at the American Society of Hematology (ASH) Annual Meeting.

Raymond Urbanski, M.D., Ph.D., Chief Executive Officer of GT Biopharma, said, “We continue to be encouraged by the data from our Trike program being conducted by leading NK cell experts at the University of Minnesota. These findings have supported us with the confidence to proceed with our first-in-class TriKE, Phase 1 study.”

GT Biopharma, Inc. (GTBP), closed Friday's trading session at $0.655, up 0.77%, on 42,372 volume with 47 trades. The average volume for the last 3 months is 186,739 and the stock's 52-week low/high is $0.579/$3.17.

chart

Khiron Life Sciences Corp. (KHRNF)

Capital Network, InvestorsHub, Pot Network, Penny Stock Hub, Stockwatch, Stockhouse, Midas Letter, Investors Hangout, TradingView, Wallmine, OTC Markets, Wallet Investor, Investing News, Barchart, Morningstar, Proactive Investors, MarketWatch, Market Screener, and GuruFocus reported earlier on Khiron Life Sciences Corp. (KHRNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Khiron Life Sciences Corp. is a Canadian integrated medical cannabis company. It has its core operations in Colombia. OTCQB-listed, Khiron is fully licensed in Colombia for the cultivation, production, domestic distribution, and global export of tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. Khiron Life Sciences has its head office in Toronto, Ontario and an office in Bogota, Colombia.

The Company combines international scientific expertise, agricultural advantages, branded product market entrance experience and education to grow prescription and brand loyalty to address priority medical conditions. These conditions include chronic pain, epilepsy, depression and anxiety in the Latin American market. Khiron is creating research partnerships with some of Colombia’s foremost medical associations – the Colombian Association of Neurology being one of them.

Additionally, the Company has the advice of the best laboratories from Israel and Canada in genetics and, production and clinical data of medical cannabis. Regarding the cultivation process and product development, Khiron has developed a temperature, humidity, and air circulation control system that ensures that the plant grows in a controlled natural environment. The Company’s cultivation is hydroponic.

Khiron Life Sciences announced in October 2018 that it signed the definitive agreement for the acquisition of the Latin American Institute of Neurology and the Nervous System (ILANS) previously announced on August 7, 2018 . ILANS is one of the most respected, fastest growing, and largest neurological clinics in Colombia. It becomes a basis of the Khiron Clinics business unit in Latin America.

This week, Khiron Life Sciences announced that it closed the earlier announced MOU (Memorandum of Understanding) with Dayacann, holder of Chile's first medical cannabis cultivation license. As the dominant medical cannabis company in Latin America, the agreement expands on Khiron's multi jurisdiction cultivation strategy, securing access to cannabis cultivation for Khiron’s use in Chile, participation in clinical trials, and access to commercialize products to meet the needs of a market of 1.8 Million patients across the nation.

Today, Khiron Life Sciences announced that it entered into a binding letter agreement, dated January 24, 2019, to acquire 100 percent of NettaGrowth International, Inc. (NettaGro), an arm's length party that will own, at the time of completion of the transaction, all the outstanding shares of Dormul S.A. (d/b/a Cannapur). Dormul has obtained the first license to produce medical cannabis with THC for commercialization in Uruguay.

Khiron Life Sciences Corp. (KHRNF), closed Friday's trading session at $1.35, up 14.40%, on 516,361 volume with 416 trades. The average volume for the last 3 months is 236,661 and the stock's 52-week low/high is $0.664/$1.586.

chart

LexaGene Holdings, Inc. (LXXGF)

Insider Financial, Stockwatch, YCharts, Metals News, The Street, OTC Markets, Dividend Investor, MarketWatch, Stockhouse, Capital Cube, Barchart, Investor Place, Pinnacle Digest, Financial Trends, and Markets Insider reported earlier on LexaGene Holdings, Inc. (LXXGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

LexaGene Holdings, Inc. develops instrumentation for pathogen detection. A biotech enterprise, the Company is developing the LX6, which is the very first fully automated pathogen detection platform that is open-access. This open-access feature will enable end-users to target any pathogen of interest, as they can load their own real-time PCR assays onto the instrument for customized pathogen detection. OTCQB-listed, LexaGene Holdings is headquartered in Beverly, Massachusetts.

The Company is working to change the pathogen detection landscape through providing a customizable sample-to-answer instrument that is faster and sensitive than anything now available. LexaGene is working to transform the way pathogen testing is performed by multi-billion-dollar industries.

LexaGene has strategic relationships with Boston Engineering – a development partner; and the Lawrence Livermore National Laboratory. The Company’s Microfluidic Technology is open access - users can load standard pathogen specific assays onto the instrument for customized testing.

The Microfluidic Technology features low cost per test and it is user-friendly. A feature of the technology is extreme sensitivity. The flow-through instrument processes large sample volumes to maximize the chances of detecting ultra-rare pathogens.

Last month, LexaGene Holdings announced the completion of a syndromic panel to detect urinary tract infection (UTI) in small animals. The assay is capable of detecting each of the eight most common pathogens responsible for the majority (95 percent) of all clinical canine UTI cases. The design of the Company's UTI panel is to detect the causative pathogens with greater sensitivity and specificity than traditional culture-based detection that is susceptible to false positive results.

This week, LexaGene Holdings announced that it has created a Scientific Advisory Board (SAB) to assist it in product positioning and its go-to-market strategy. The SAB consists of key opinion leaders in LexaGene’s targeted markets, specifically food safety, veterinary diagnostics, and open-access markets such as biodefense. Initial SAB members include Dr. Kimothy Smith DVM PhD and Mr. Shawn Stevens JD.  Other SAB members will be added over the coming months to complete a five-member advisory board.

LexaGene Holdings, Inc. (LXXGF), closed Friday's trading session at $0.598405, up 0.68%, on 1,472 volume with 5 trades. The average volume for the last 3 months is 41,506 and the stock's 52-week low/high is $0.349/$1.159.

chart

Natural Health Farm Holdings, Inc. (NHEL)

4-Traders, Street Insider, Morningstar, Simply Wall St, InvestorsHub, OTC Markets, GuruFocus, MarketWatch, Stockopedia, Stockhouse, Market Exclusive, last10k, Barchart, and CapitalCube reported previously on Natural Health Farm Holdings, Inc. (NHEL), and today we chose to report on the Company, here at the QualityStocks Daily Newsletter.

Natural Health Farm Holdings, Inc. is a biotechnology company working to form a complete healthcare one-stop shop based on natural or naturopathic products. Since November 2017, the Company has developed and started to commercialize the web-based Naturopathic Learning Management System to enable consumers and distributors to be educated on health-related aspects of different diseases and nutritional consulting services. Natural Health Farm Holdings is based in Las Vegas, Nevada.

The Company provides online nutritional consultation services. It does so through offering a web-based naturopathic learning management system. This system educates their customers on general wellbeing. Natural Health Farm’s chief activities are in retailing nutritional supplements, organic foods and health-care related products.

Through its subsidiary, NHF International Limited, Natural Health Farm specializes in biotechnology research & development, and a retail business. It has a chain of manifold retail & franchise outlets located throughout Malaysia and other nations. These include Singapore, Brunei, Philippines, China, Hong Kong and the United States.

Earlier this month, Natural Health Farm Holdings, announced that it executed a term sheet to acquire all of the issued and outstanding shares of Natural Tech R&D Sdn Bhd, a BioNexus accredited research and development company in Malaysia. With this agreement, Natural Health Farm Holdings shall acquire 100 percent of Natural Tech R&D’s outstanding shares for USD 1 Million.

Last week, Natural Health Farm Holdings announced that it executed a term sheet to acquire all of the issued and outstanding shares of Excel Herbal Industries Sdn Bhd. Excel Herbal is a nutraceutical biotechnology manufacturing, organic food and health supplements enterprise in Malaysia.

With this agreement, Natural Health Farm Holdings shall acquire 100 percent of Excel Herbal Industries’ outstanding shares for USD 2 Million. The anticipation is that Natural Health Farm Holdings shall complete the due diligence process and close the transaction within 60 calendar days from the term sheet date.

Natural Health Farm Holdings, Inc. (NHEL), closed Friday's trading session at $0.79, down 2.47%, on 32,114 volume with 28 trades. The average volume for the last 3 months is 23,686 and the stock's 52-week low/high is $0.20/$6.00.

chart

Organigram Holdings, Inc. (OGRMF)

Penny Stock Tweets, Wallet Investor, Marijuana Stock, Marijuana Stocks Report, CFN Media Group, Investor Place, Wealth Daily, Daily Marijuana Observer, TradingView, Microcap Daily, The Street, Cannabis Financial Network News and Money Morning reported on Organigram Holdings, Inc. (OGRMF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Organigram Holdings, Inc.’s focus is on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada. The Company’s wholly-owned subsidiary, Organigram, Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram has developed a portfolio of brands. These include The Edison Cannabis Company, Ankr Organics, Trailblazer and Trailer Park Buds. The Company’s head office, production facility, and Research and Development (R&D) are in Moncton, New Brunswick.

Organigram has collaborations with healthcare experts and academic institutions. It invests in medical education, outreach, as well as research for the use of cannabinoids as a first line of treatment. Organigram provides a diverse assortment of genetics and product types. These cater to the individual needs of each client. The Company offers a reliable supply of premier quality, industry-leading strains to match individuals’ personal needs.   

Organigram is undergoing a production-facility expansion. This expansion will more than triple the size of its operations. The multi-million-dollar project will meet the increasing needs of its medical patient base, and prepare it for the legal, adult-recreational marijuana market.

Moreover, the Company’s plans include a production-capacity increase from approximately 5,200 kilograms (kg) annually to greater than 25,000 kg annually. In addition, plans include the acquisition of a third building at 55 English Drive for future expansion, next to the present campus.

This week, Organigram Holdings announced it entered into an agreement with 1812 Hemp, a New Brunswick based industrial hemp research company to secure supply and support research and development on the genetic improvement of hemp via traditional plant breeding methods. 1812 Hemp is centered on further developing a line of Canadian cultivars (specific varieties of plants cultivated to enhance desirable qualities) of high cannabidiol (CBD) yielding hemp for the Canadian climate. With this agreement, Organigram will have access to a secure supply of hemp flower that contains significant levels of cannabidiol (CBD cultivars ranging from 4 percent to 8 percent).

Additionally, this week, Organigram Holdings announced it made changes to its compassionate care model by developing OrganiCare. This is a program designed to improve access to medical cannabis for low-income patients. Effective immediately, patients who earn an annual income of less than $35,000 per year qualify for OrganiCare, Organigram’s new program, which offers qualified patients a 30 per cent price reduction on all dried cannabis products and oils. The Company's Compassionate Care Program was voted best in Canada at the Canadian Cannabis Awards in 2017.

Organigram Holdings, Inc. (OGRMF), closed Friday's trading session at $4.50, down 2.39%, on 678,540 volume with 1,531 trades. The average volume for the last 3 months is 537,349 and the stock's 52-week low/high is $2.57/$6.68.

chart

Smoke Cartel, Inc. (SMKC)

NetworkNewsWire, The Street, Penny Stock Hub, Stock News Feed, Wallmine, OTC Markets, Stockhouse, Street Insider, Investors Hangout, Dividend Investor, TradingView, Stockopedia, Stockwatch, 4-Traders, Wallet Investor and InvestorsHub reported previously on Smoke Cartel, Inc. (SMKC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Smoke Cartel, Inc. is a foremost online retailer and wholesaler of glass water pipes, vaporizers, and other related accessories for the cannabis industry. The Company began operations in 2014 in the State of Georgia. It was previously known as Lemont, Inc. It changed its name to Smoke Cartel, Inc. in August of 2017. Smoke Cartel has its corporate office in Savannah, Georgia.

The Company operates in different verticals within the online headshop industry. This comprises, but is not limited to, the sales of consumer products through online retail, sales of wholesale products to other retailers, the design and manufacturing of branded products, and shipping and fulfillment services. Smoke Cartel’s retail division has more than 90,000 customers in 44 countries.

Smoke Cartel previously acquired and undertook the integration of UPC Distribution into Glassheads Distribution, the wholesale division of Smoke Cartel. It has subsequently rebranded its Glassheads Distribution division as Smoke Cartel Wholesale. In addition, the Company acquired and integrated Early Bird Distribution and all of its brands. As a result, this expanded Smoke Cartel into new markets, such as the pet industry.

The Company has covered a broad niche of glassware. Its plan is to concentrate on non-glass products and accessories in the future to expand product selection and to reach new markets. At present, Smoke Cartel has nine branded product lines to serve varied demographics in the smoking accessory market.

Recently, Smoke Cartel launched AskVape.com, a one-stop online vape shop. The site offers vaporizers, e-juice, vape parts, and accessories all in one convenient location. Its “Autoship” offers customers a discount when they set up recurring orders for their convenience. Enthusiasts can find top-ranked vaporizer and vaporizer accessory brands at AskVape.com, in addition to a growing list of informative articles.

Also recently, Smoke Cartel announced that its Smoke Cartel Wholesale division will attend Denver’s INDO EXPO Trade Show this weekend. At this event, Smoke Cartel will showcase such exclusive and popular in-house product lines as High Times Cannabis Cup “Best Glass” Winner, Sesh Supply, newly acquired Roll-Uh-Bowl silicone water pipes, and the cannabis-themed pet accessories of HeadyPet.

Smoke Cartel, Inc. (SMKC), closed Friday's trading session at $0.80, down 11.11%, on 400 volume with 1 trade. The average volume for the last 3 months is 1,740 and the stock's 52-week low/high is $0.51/$6.25.

chart

Digatrade Financial Corp. (DIGAF)

MarketWatch and InvestorsHub reported earlier on Digatrade Financial Corp. (DIGAF), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Digatrade Financial Corp. is an international digital asset exchange and blockchain development services company. It engages in the licensing, development, and branding of a digital exchange trading platform and a peer to peer electronic payment processing network for enabling users to trade fiat and alternative currencies. In essence, DIGATRADE is a Digital Asset, Currency (Bitcoin) Exchange, and Internet Financial Services Company owned and operated by Digatrade Financial Corp.

Established in 2000, the Company lists on the OTC Markets’ OTCQB. It formerly went by the name Bit-X Financial Corporation. It changed its corporate name to Digatrade Financial Corp. in October 2015. Digatrade Financial has its head office in Vancouver, British Columbia.

Currently, Digatrade Financial is developing several new technologies for the Digatrade Core 2.0 Digital Asset Trading Platform. In addition, the Company is seeking more new opportunities and partners for growth as Bitcoin (BTC) continues to increase in value with a market capitalization now in excess of $23.5 Billion.

Digatrade has launched the Digatrade OTC Trade Desk. The new Digatrade Over-the-Counter (OTC) trading service will let KYC verified customers to complete trades outside the online liquidity order book at competitive market prices.

Digatrade Financial provides operational support specializing in web-based digital currency exchange and transaction services for the cryptographic digital currencies. This includes Bitcoin and other alternative digital coins.

The Company provides a user-friendly, secure, and affordable platform to buy and sell Bitcoin and other digital assets. Digatrade provides a 24-hour online platform. This platform provides the automated matching of orders between its registered members.

The proprietary Digatrade trading and matching engine manages high volume, high throughput, and low latency trading. Also, this engine features blended multi-currency settlement in addition to real time FX pricing and risk management fully powered by ANX Technologies. The order engine delivers pre-scan indicative pricing. Users can decide to either fix the quantity of Bitcoins or fix the price paid for every order.

Recently, Digatrade Financial announced the listing addition of Ethereum ''ETH'' paired to BTC on the trading platform. This will afford Digatrade customers and shareholders first access to register for the Digafund21 (D21) token release on the already established, safe, and secure Digatrade platform. At present, the Company is now evaluating security protocol to increase crypto-currency pairings, which may include DASH, EOS, BITCOIN CASH, TETHER, MONERO, MERCURY, ZCASH, and NEO, among others.

Digatrade Financial Corp. (DIGAF), closed Friday's trading session at $0.0067, up 11.67%, on 2,051,181 volume with 30 trades. The average volume for the last 3 months is 7,633,700 and the stock's 52-week low/high is $0.001/$0.3389.

chart

MannKind Corporation (MNKD)

MarketWatch, InvestorsHub, Bloomberg, and Stockhouse reported on MannKind Corporation (MNKD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A biopharmaceutical enterprise, MannKind Corporation concentrates on the development and commercialization of inhaled therapeutic products. These products are for patients with diseases such as pulmonary arterial hypertension and diabetes. Additionally, MannKind employs field sales and medical representatives throughout the United States. The Company is based in Westlake Village, California. It also has a state-of-the art manufacturing facility in Danbury, Connecticut.

At present, MannKind is commercializing Afrezza® (insulin human) inhalation powder. This is MannKind’s first Food and Drug Administration (FDA)-approved product. Afrezza® is the only inhaled rapid-acting mealtime insulin in the U.S. It is available in the U.S. by prescription from pharmacies across the country.

Afrezza® is available via prescription only. It is a rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. MannKind’s single-use and reusable Inhalers are breath-powered. Therefore, they require only the patient’s inhalation effort to deliver the powder. One breath delivers one dose. The Company’s inhalers efficiently focus the energy supplied by the patient’s breath directly onto the dry powder. This results in high delivery performance.

Afrezza® is taken at the beginning of a meal utilizing the specially designed inhaler. Afrezza®   dissolves quickly upon inhalation to the deep lung. It delivers insulin fast to the bloodstream. Peak insulin levels are attained within 12 to 15 minutes of use and help to control post-meal blood sugar spikes, which affect HbA1C levels.

Afrezza® uses the Company’s proprietary Technosphere® formulation technology. The basis of this technology is on a class of organic molecules designed to self-assemble into small particles onto which drug molecules can be loaded.

Afrezza® underwent study in greater than 60 different clinical trials, evaluating more than 3,000 people living with Diabetes type 1 and type 2. Afrezza is covered by diverse national and regional insurance plans where MannKind offers a saving card. This card decreases the co-pay for most commercially insured patients to as little as $15.

The Company’s family of oral inhalation technologies consists of dry powder formulations (Technosphere® technology), user-friendly, breath-powered inhalers, as well as an integrated formulation/inhaler approach, including inhalation profiling, designed to speed up the drug development process.

MannKind’s pipeline includes Epinephrine Technosphere® for anaphylaxis; and Treprostinil Technosphere® for Pulmonary Arterial Hypertension (PAH). The Company’s pipeline also includes Palonosetron Technosphere® for Chemotherapy-Induced Nausea and Vomiting (CINV).

Recently, MannKind announced its support for Hurricane Maria victims in Puerto Rico with a donation of Afrezza® (insulin human) inhalation power. This donation will be delivered by way of American Family Airlift (AFA). AFA is a relief organization founded by Mr. Hector Hoyos and Dr. Cesar Sierra, who are two Puerto Rican natives passionate about assisting those in need. AFA has partnered with several hospitals and organizations to help with their relief efforts.

MannKind Corporation (MNKD), closed Friday's trading session at $1.29, up 0.78%, on 3,286,941 volume with 8,596 trades. The average volume for the last 3 months is 2,224,921 and the stock's 52-week low/high is $0.939/$4.05.

chart

Graphene 3D Lab, Inc. (GPHBF)

Agora Financial, OTC Markets, and Stockhouse reported on Graphene 3D Lab, Inc. (GPHBF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Graphene 3D Lab, Inc., by way of its wholly-owned subsidiary, Graphene Laboratories, Inc., develops, manufactures, and markets proprietary graphene-based nanocomposite materials for diverse types of 3D printing. This includes fused filament fabrication. Additionally, the Company engages in the manufacture and sale of graphene materials and nanocomposite enhanced polymers via Graphene Laboratories. Graphene is a single-layer of carbon atoms. Graphene is considered a wonder-material for its high strength, conductivity, as well as ultra-light-weight.

Listed on the OTCQB, Graphene 3D Lab is headquartered in Calverton, New York. The Company’s facility is also in Calverton. This facility is equipped with material processing and analytical equipment. The Company’s go-to-market product is Conductive Graphene Filament. Graphene 3D Lab has its Industrial Materials Division to commercialize graphene composite materials.

Graphene 3D Lab also engages in the design, manufacture, and marketing of 3D printers and related products for domestic and global customers. The Company centers on the development and commercialization of technologies, which improve the capabilities of 3D printing.

Its 3D printing division provides a suite of specialty fused fabrication filaments. Also, Graphene 3D Lab owns a new proprietary technology covering the preparation and separation of graphene's atomic layers.

Conductive Graphene Filament brings users the ability to 3D print circuitry and sensors for electronic applications. Graphene 3D Lab introduced a new functional magnetic filament to its product line in 2016. The new filament was developed by Graphene 3D. It enables printing of 3D projects with components that are attracted to magnetic fields. The Company said that the filament is ideal for producing sensors and mechanical actuators and motors by additive manufacturing.

Graphene 3D Lab announced earlier this year the commercial release of two new additions to the G6-Epoxy™ product line of advanced adhesive materials. This product line includes innovative carbon-silver adhesive materials that are built on technology, which has undergone development by its Industrial Division. The new epoxies are highly electrically conductive adhesives with a proprietary formula based on the combination of graphene and silver fillers and other additives.

The Company and AzTrong, Inc. (AzT) announced this past June the signing of a Memorandum of Understanding (MoU). This MoU outlines the terms of the Strategic Alliance Agreement to be executed forthcoming. The aim of the Alliance is to capitalize on Graphene 3D Lab’s extensive base of customers and wide-ranging Intellectual Property (IP) portfolio in the graphene sector.

AzT will contribute its large-scale manufacturing base with well-developed infrastructure in the U.S. and Taiwan. The desired outcome is cost-effective production of performance-improving graphene-based products with a focus on the energy storage, construction, automotive, and defense sectors.

Graphene 3D Lab has released the Graphene-HIPS 3D Printing Filament. Graphene-HIPS is a distinctly engineered and unique semi-flexible FDM 3D Printing material reinforced with graphene. The design of it is for high performance 3D printing. The FDM material exhibits first-rate interlayer adhesion, toughness, and premier impact resistance.

At the end of July 2017, Graphene 3D Lab announced that Mr. Roman Rabinovich was appointed to the Board of Directors, effective immediately. He serves as a Senior Director at FTI Consulting. Mr. Rabinovich has considerable experience in strategic development, transaction advisory, litigation support, and business restructuring engagements. His specialty is analysis of corporate finance and building optimal pricing strategies to improve sales growth.

Graphene 3D Lab, Inc. (GPHBF), closed Friday's trading session at $0.05, even for the day, on 30,550 volume with 18 trades. The average volume for the last 3 months is 50,898 and the stock's 52-week low/high is $0.031/$0.183.

chart

NexOptic Technology Corp. (NXOPF)

Stockhouse, InvestorsHub, Equedia, and MarketWatch reported on NexOptic Technology Corp. (NXOPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NexOptic Technology Corp. has an option to acquire, in the aggregate, 100 percent of Spectrum Optix, Inc., a private corporation (Calgary, Alberta). Essentially, at this time, the Companies are working as a single corporation; with their respective Chief Executive Officers (CEOs) sitting on each other's Boards of Directors. Spectrum Optix is developing technologies relating to imagery and light concentration applications. NexOptic Technology lists on the OTC Markets Group’s OTCQB. The Company is based in Vancouver, British Columbia.

Employing Blade Optics™, Spectrum Optix’s set of patent-pending optical technologies, Spectrum aims to increase aperture sizes within given depth constraints of various imaging and non-imaging optical applications. The two Companies believe that Blade Optics™ has the potential to breakdown many of the limitations associated with conventional, curved lens stacks.

Earlier in 2017, Spectrum Optix completed its proof-of-concept digital telescope prototype (POC). It uses a patent-pending Blade Optics™ technology, other optical elements, as well as electronic components. The intention of this prototype is to demonstrate the marketable features of Spectrum's Blade Optics™ technology and its potential to serve as a platform to be utilized in different optical applications.

This past June, NexOptic Technology and Spectrum Optix announced that, further to their joint news release dated April 4, 2017, they have successfully completed the engineering trade study of a new telephoto lens stack design intended for mobile devices, including smartphones. Spectrum Optix filed a patent application with the United States Patent and Trademark Office (USPTO) related to its new design. Completion of the engineering trade study is the initial step in the Companies' plan to grow their optical technology pipeline.

Recently, NexOptic Technology and Spectrum Optix announced that NexOptic satisfied all of the cash expenditure requirements under its option to acquire 100 percent ownership interest of Spectrum Optix pursuant to the agreement between NexOptic, Spectrum, and Spectrum's shareholders dated October 22, 2015. NexOptic Technology further announced that its plan is to exercise its final option and complete the acquisition of Spectrum Optix on or about October 2017.

Upon completion of this Agreement, key management members of Spectrum Optix and NexOptic Technology will be appointed to the senior management and Board of Director positions of NexOptic Technology. NexOptic’s patent-pending optical technologies and lens stack designs are scalable to diverse sizes. They can be manufactured utilizing readily available optical materials.

NexOptic Technology Corp. (NXOPF), closed Friday's trading session at $0.44, up 0.45%, on 19,583 volume with 17 trades. The average volume for the last 3 months is 23,271 and the stock's 52-week low/high is $0.3865/$1.156.

chart

CVR Medical Corp. (CRRVF)

OTC Markets and MarketWatch reported on CVR Medical Corp. (CRRVF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CVR Medical Corp. is engaged in an equal part joint venture (JV) with CVR Global, Inc. The JV operates in the medical industry centered on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology. A medical technology enterprise, CVR Medical is headquartered in Vancouver, British Columbia and the Company’s shares trade on the OTC Markets Group’s OTCQB.

The JV has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. The Carotid Stenotic Scan (CSS) is a unique tool that will be used to assess Carotid Arterial health in a way that is unavailable to the patient, healthcare provider, and the payor within the present system.

The CSS is a screening tool designed to detect and measure carotid arterial stenosis or occlusion for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool that complements other stroke screening technology. The screening device is non-emissive and non-invasive. It does not require a certified technician and can be conducted in a few minutes.

The CSS has a per scan price point that is significantly advantageous as an initial screening tool versus the resource requirement associated with other technologies. CVR’s technology makes a connection between fluid flow and sub-sonic frequencies to ascertain the presence of arterial disease/blockage.

CVR Medical is entering the Clinical phase of the development process. The final market version of the CSS is undergoing assembly and preparation for Pivotal Trials, which will then undergo submission for Food and Drug Administration (FDA) 510(k) clearance.

CVR Medical reported in March of this year that it entered into a letter of intent (LOI) with CVR Global, Inc. to acquire an additional 10 percent interest of the "Joint Venture Business" from CVR Global's present 50 percent interest. The Joint Venture Business is held pursuant to, and governed by, the terms of the Joint Venture Agreement between CVR Global and CVR Medical.

Upon the closing of the Transaction, the Joint Venture Business and related assets will be transferred into a new corporate entity to be created for the continuing ownership and operation of the business.

Furthermore, in March, CVR Medical announced a partnership with ADCO Circuits. ADCO will be the exclusive provider of the custom circuit board inside the sensor of CVR Medical's Carotid Stenotic Scan (CSS) device. ADCO Circuits is a Michigan-based electronic design and manufacturing enterprise.

In April, CVR Medical announced an update on clinical trials of the Carotid Stenotic Scan (CSS), being conducted by way of the Jefferson Clinical Research Institute at Thomas Jefferson University under the supervision of Dr. David J. Whellan.

Dr. Whellan said, "Enrollment was initiated in early January. The prototype device, which is being operated in standard form, will soon be joined by its wireless charging technology, for which preparation has gone smoothly. The CSS, as a whole, has been widely praised for its ease of use. The training required was straightforward and allowed the coordinators to quickly gain experience and implement the study. Since its successful implementation, we have had steadily growing enrollment. We're looking forward to continuing our work with CVR."

Recently, CVR Medical advisory staff member Dr. Phillip J. Bendick, PhD, released a summarized report on data from the tertiary clinical trials for the Carotid Stenotic Scan (CSS) device at Thomas Jefferson University. His report views initial evaluations as successful, and confirms the device's value and efficiency.

Also recently, CVR Medical announced that an institutional research report was released by RB Milestone Group, LLC (RBMG). This report on CVR Medical titled "Revolutionizing the Vascular Diagnostics Market" can be found on the website at www.CVRMed.com or by contacting Trevor Brucato, Managing Director at RBMG. RB Milestone Group is a New York based consulting firm that CVR Medical engaged to provide the report.

CVR Medical Corp. (CRRVF), closed Friday's trading session at $0.181, up 1.74%, on 146,520 volume with 22 trades. The average volume for the last 3 months is 78,608 and the stock's 52-week low/high is $0.164/$0.385.

chart

All for One Media Corp. (AFOM)

OTC Markets, Street Register, MarketWatch, InvestorsHub.com, and Barchart reported on All for One Media Corp. (AFOM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

All for One Media Corp. is a tween marketing company listed on the OTCQB. The estimation is that the tween demographic is responsible for no less than $260 billion yearly in direct sales in the U.S. alone. Called “Generation I” for "Internet," this generation's tweens represent the first demographic to have had only known life with the Internet and social media. Essentially, All for One Media is a marketing brand changing the mindset of tweens that bullying is unacceptable.  All for One Media has its corporate office in Mount Kisco, New York.

At present, the Company is producing "Crazy For the Boys." All for One Media, through entertainment, is working to deliver a message, which will resonate with kids to impact the epidemic of bullying and cyber-bullying. Also, the Company is working to help individuals who have been affected by bullying to deal with it in a positive and constructive way.

“Crazy For The Boys” is a full length coming of age musical dramedy. It features Groovy Tuesday music and choreography. The film tells the story of five high school girls from five very different cliques who must work together to run their school’s anti-bullying organization. The film features original pop songs concerning peer pressure, unrequited love, and teen angst.

The expectation is that “Crazy For The Boys” will generate revenues from a number of sources. These include domestic and global distribution, video on demand (VOD), merchandising, soundtrack, live performances, and other ancillary sources.

All for One Media has initiated the recording of the sixteen songs that will be included in "Crazy for the Boys", as well as included on the Soundtrack for the movie. Several songs will be produced by multi-platinum Producer Jeff Coplan. Recording began on May 2, 2017 at legendary studio "The Jungle Room" in Glendale, California.

In May last year, All for One Media announced that it received a commitment letter from its production partner Sunset Pictures. This is for domestic distribution for the motion picture Crazy for the Boys through its output deal with 20th Century Fox, inclusive of theatrical release via Atlas Distribution, and all ancillary rights including Netflix, Cable, and Network TV, and DVD, Blue ray, VOD, Digital, and more. Sunset Pictures will facilitate Print and Ad Funds to boost the marketing of the theatrical release and the marketing of the film.

Recently, All for One Media, by way of its wholly-owned subsidiary, Crazy for the Boys movie, LLC, announced the casting of former "Saturday Night Live" star, Cheri Oteri in its upcoming feature film as the Principal of JFK High School. The upcoming musical dramedy began shooting on July 5, 2017 in Savannah, Georgia. Cheri Oteri is famous for being one of the cast members on Saturday Night Live from 1995 to 2000. Crazy for the Boys is being marketed as a modern day "Grease." Crazy for the Boys is targeting a Spring Break 2018 theatrical release.

All for One Media Corp. (AFOM), closed Friday's trading session at $0.094, up 4.56%, on 146,520 volume with 22 trades. The average volume for the last 3 months is 78,608 and the stock's 52-week low/high is $0.0265/$0.225.

chart

CloudCommerce, Inc. (CLWD)

Wolf of Penny Stocks, Epic Stock Picks, MoneyTV, and Investor News Source reported earlier on CloudCommerce, Inc. (CLWD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CloudCommerce, Inc. is a provider of cloud commerce services to top brands. The Company is a global provider of cloud-driven e-commerce and mobile commerce solutions. Furthermore, CloudCommerce strategically acquires profitable cloud commerce solutions providers with strong management teams. The Company’s objective is to be a full-service provider of cloud commerce solutions for medium, large, and worldwide enterprises. CloudCommerce is headquartered in Santa Barbara, California.

CloudCommerce’s services include the development of highly customized and sophisticated online stores; real-time integration to other business systems; digital marketing and data analytics; complete and secure site management; and integration to physical stores. CloudCommerce’s goal is to capitalize on the growth in technology industry subsets: Security Technology, Cloud Computing, Business Analytics, Storage, and Wireless, through acquiring strong companies in a roll-up strategy.

Through acquiring experts in e-commerce, digital marketing, and enterprise commerce solutions, Company Management is working to build an e-commerce super-competitor that lets each subsidiary operate autonomously while combining resources and sharing ideas to create cost savings and cross-marketing opportunities.

Further to development, CloudCommerce can also totally manage its customer solutions with services. These include technology consulting, continuing maintenance, hosting infrastructure build out and management.

The Company acquired Indaba Group (Denver, Colorado). Indaba is an e-commerce developer centering on the Magento platform. The acquisition of Indaba Group brings a profitable and growing operation into CloudCommerce’s operations, which meshes well with its current e-commerce development operations.

Indaba Group is a strategic e-Commerce agency. Indaba specializes in enterprise software development, e-Commerce platform development, creative services, and customer experience management

Recently, CloudCommerce announced the launch of its new digital marketing division. The new division will provide services including Content Marketing, Marketing Automation, Social Media Strategy/Marketing, Search Marketing, Account-Based Marketing, Sales Enablement, Data Analytics, and Brand Strategy/Brand Experiences.

The Company’s intention is to expand into these areas of focus via direct sales efforts to existing clients, prospective clients and joint partnerships, and through the strategic acquisition of digital marketing services firms.

Recently, CloudCommerce announced the execution of a merger agreement under which it acquired 100 percent of Parscale Creative, Inc. Parscale Creative consists of certain assets spun out of Giles-Parscale, Inc., a San Antonio-based enterprise owned by Brad Parscale and Jill Giles. After closing the transaction, Parscale Creative was renamed Parscale Digital, Inc. Parscale is a fast-growing provider of enterprise digital marketing services.

CloudCommerce, Inc. (CLWD), closed Friday's trading session at $0.02, up 36.05%, on 100,000 volume with 3 trades. The average volume for the last 3 months is 70,560 and the stock's 52-week low/high is $0.008/$0.04.

chart

The QualityStocks Company Corner

Cyberfort Software, Inc. (CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

Cybersecurity companies such as Cyberfort Software Inc. (OTC: CYBF) are becoming a modern necessity amid an ever-increasing number of data attacks on unsuspecting personal and corporate computer systems. Cyberfort Software’s mission to provide powerful and responsive solutions to cyber-attacks promotes the networking worth of both individuals and business users as they interact across multiple platforms.

Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.31, up 99.74%, on 54,449 volume with 31 trades. The average volume for the last 3 months is 16,722 and the stock's 52-week low/high is $0.051/$69.00.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

With the recent advent of new products with cannabidiol (CBD)-infused formulas hitting the market, the potential for the next big entry into the cannabis sector could come from a personal care products giant. A potential partnership with a personal care products major could come through one of the companies is developing new CBD products, such as Green Growth Brands (CSE:GGB) (OTC:GGBXF). The medical benefits of the non-psychoactive cannabinoid called cannabidiol (CBD) have been known for over 10 years. Now CBD products have become an instant hit among multiple demographics, and is moving from the fringe to mainstream acceptance.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $4.274, off by 1.62%, on 102,356 volume with 384 trades. The average volume for the last 3 months is 165,221 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

Canadian Licensed Producer of premium cannabis products The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) today announced that it has hired Deron Caplan as its director of plant science. To view the full press release, visit: http://nnw.fm/3qyqD. Also today, NetworkNewsWire released a report on the company detailing how The Flowr Corporation has designed and built 17 cultivation facilities to date, relying on innovative processes to ensure high yields and low production costs. This methodology could give Flowr a competitive advantage moving forward as anticipated changes occur in the cannabis sector.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $3.73, up 0.81%, on 54,565 volume with 150 trades. The average volume for the last 3 months is 72,746 and the stock's 52-week low/high is $2.84/$8.00.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, this morning announced that it has entered into a definitive agreement with Queen Genetics/Knud Jepsen A/S (“Knud Jepsen”) to establish two 50/50 joint ventures (“JVs”). To view the full press release, visit: http://nnw.fm/KgDV1. Also today, the company was listed among the Virtual Investor Conferences and KCSA Strategic Communications agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series.  Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:45 AM ET, with the first live webcast at 10:00 AM ET, on Wednesday, January 30. REGISTER NOW AT: https://tinyurl.com/0130CannabisVIC.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.82, up 7.63%, on 2,066,904 volume with 2,603 trades. The average volume for the last 3 months is 944,513 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Transcanna Holdings Inc.(CSE: TCAN, Frankfurt: TH8), and its specialization in branding, transportation, distribution, and fulfillment services for the legal cannabis industry. Also today, the company was highlighted featured in a report by CannabisNewsWire examining how it is still illegal to consume recreational marijuana in Missouri, but prosecutors in several urban areas there have decided to stop going after people found in possession of small amounts of cannabis.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $1.92, up 2.13%, on 181,842 volume with 126 trades. The stock's 52-week low/high is $0.769/$2.00.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) was featured in a report today from CannabisNewsWire looking at how marijuana law reform advocates welcomed the recent  Missouri announcement about relaxed prosecutions for possession of small amounts of cannabis and expect many other urban authorities to take similar action since there is growing pressure to end prohibition and adopt legalization and regulation of marijuana.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.649, up 3.28%, on 266,186 volume with 105 trades. The average volume for the last 3 months is 341,906 and the stock's 52-week low/high is $0.413/$3.24.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (OTCQB: MCOA), an innovative hemp and cannabis corporation, announced on January 10 that clone production at the Scio, Oregon, high yielding CBD hemp project is underway. MCOA and joint venture partner Global Hemp Group Inc. (OTC: GBHPF) (CSE: GHG) (FRANKFURT: GHG) are preparing to begin planting as early as possible in 2019, which will have a positive effect on the length of the growing season (http://nnw.fm/sUe2D).

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0148, up 0.68%, on 7,310,280 volume with 259 trades. The average volume for the last 3 months is 13,433,931 and the stock's 52-week low/high is $0.0115/$0.0498.

Recent News

chart

Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Emerging business development technology innovator Pacific Software Inc. (OTC: PFSF) announced earlier this month that its anticipated e-commerce platform for international transactions, known as BOAPIN, will soon begin to register new buyers and sellers as it builds a virtual Silk Road for trade between China and South America.

Pacific Software, Inc. (PFSF) is an emerging technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is building “BoaPin,” a subscription-based e-commerce trading platform focused on cross border trade expansion with an international emphasis. The multi-faceted e-commerce platform is scheduled for launch in Q1 of 2019.

The Company is uniquely positioned to deliver a B2B and B2C intelligent e-commerce trade platform which will provide various solutions, data, applications and tools for subscribers, including IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure, multi-lingual communication, fintech, digital marketing, smart contracts, commodities search/match applications, customs clearance, taxation data, product advertising and logistics solutions.

Through smart contract technology for global supply chain management, BoaPin is designed to improve product traceability and deliver solutions to its subscribers for product certification, marketing, logistics, commodities search/match interface, trade finance, cross border payment solutions and customs clearance. Some of the tools available to execute these capabilities include cross border payments, blockchain solutions, smart contracts and multilingual access.

With these features at hand, the company is targeting several key industries where its online applications and solutions could have significant corporate impact in various forms, including: agriculture, fertilizers, chemicals, cosmetics, electronics, equipment, apparel and controlled substance management.

Business Model

Pacific Software initially will focus on Brazil and China for BoaPin. After paying a registration fee to utilize the online trade portal, subscribers to the platform will have access to a variety of tools and features that may enhance and increase revenue initiatives by showcasing their commodities and products for sale or trade.

Buyers of the commodities, products or services will pay a transaction fee only to the company which could materialize in the form of cash, cash equivalents, royalties or in-kind fees.

As the company executes its strategy, the online trade business is anticipated to generate significant revenue from subscribers obtained from regionally and federally organized Brazilian Trade Associations. The members wish to market their commodities or products, and the portal users or buyers materialize from China, Hong Kong and surrounding countries. As a result, this business model may be organized separately in the company’s wholly owned subsidiary, incorporated as HyperSoft Ventures, which could generate appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, even for the day. The stock's 52-week low/high is $3.50/$5.50.

Recent News

chart

Icon Exploration Inc. (TSX.V: IEX.H)

The QualityStocks Daily Newsletter would like to spotlight Icon Exploration Inc. (IEX.H).

Icon Exploration (TSX.V: IEX.H), through its pending reverse takeover of City View Green, has ideally positioned itself to capitalize on the recent shifting of both laws and attitudes regarding cannabis. To view the full article, visit: http://nnw.fm/dG3sI.

Icon Exploration Inc.'s (TSX.V: IEX.H) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.

Management

Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

Icon Exploration Inc. (TSX.V: IEX.H), closed the day's trading session at $0.41, even for the day, on 86,680 volume.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Mary’s Wellness Ltd. and Winterlife Inc., two portfolio clients of Redfund Capital (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4), recently created a strategic alliance for a global cannabis product launch as recent developments in the North American cannabis market present new opportunities. To view the full article, visit: http://nnw.fm/wW6OW.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.2073,even for the day. The average volume for the last 3 months is 287 and the stock's 52-week low/high is $0.10/$0.505.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures Inc. (OTC: NUGS) recently added a number of cannabis industry insiders to its executive team and board of directors. In October 2018, the company announced the appointment of Alan Tran to its board of directors. Tran brings strong financial and strategic skills to Cannabis Strategic Ventures, having led several successful management, consulting and financial teams, not only within the cannabis, health care and technology market sectors, but also within leading Fortune 500 companies.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.60, off 5.33%, on 233,174 volume with 272 trades. The average volume for the last 3 months is 79,963 and the stock's 52-week low/high is $1.02/$5.94.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Headquartered in Vancouver, Canada, with operations in San Diego, Calif., Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)  is a premium food and beverage company that focuses on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses active hemp into a variety of premium foods, beverages and supplements and is poised for global distribution. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s mission is to become a leader in whole plant solutions by providing holistic remedies for a more natural alternative to pharmaceuticals and by guiding people toward a healthy lifestyle. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages and a focus on holistic health and wellness.

Publicly traded on the Canadian Securities Exchange (CSE: VIDA) and the OTCQX Best Market in the U.S. (OTC: PHVAF), the company’s strong balance sheet carries CAD$13 million with no debt or loans with ~60 million shares outstanding, and the company is now well-capitalized to fund major mainstream distribution with a solid structure that is poised for long-term growth.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who, as Phivida’s chief commercial officer, is tasked with driving new sales revenue growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

The whole plant hemp extract is infused into functional beverages, food and supplements to target a range of health and wellness conditions. Phivida strives to lead the industry in product quality through high-quality ingredients and best-in-class testing. The Company has partnered with Flora Labs to test and ensure consistency and potency of all products. Flora Labs is a world-class testing lab with stringent QA and QC quality assessment protocols and will provide Phivida with ongoing impartial quality testing.

Regulations

Federally legal under the 2014 Farm Bill, CBD from hemp oil is a rapid growth market across the U.S. When derived from marijuana, CBD remains a schedule 1 controlled substance, giving hemp-derived CBD oil-infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the U.S. Industrial Hemp laws to an agricultural commodity status and effectively removing hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the U.S. CBD-hemp sector. In February 2018, the Supreme Court presided over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp and the legality of industrial hemp. In the final ruling, the Supreme Court unequivocally determined that hemp (and its derivatives), when produced domestically under the Farm Bill, are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA), giving the Farm Bill primary jurisdiction over the governance of the CBD-hemp oil industry in the U.S.

The DEA further conceded it does not “seek to control cannabinoids” and that only marijuana-derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g., U.S. Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreational cannabis, with edibles to be added in 2019. The bill officially became law as of Oct. 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

Phivida Brands

  • Vida+: Vida+ is the company’s premium, clinical-grade-strength, full-spectrum hemp oil extract and capsule line designed to help people feel their best. The products are sourced from the best organic hemp and natural ingredients on the market and are third-party lab tested for quality, purity and potency at world-class facilities.
  • Oki: The Oki lifestyle brand is the company’s newly launched line of functional beverages and supplements infused with active hemp extract and will be available to consumers in up to 2,400 natural specialty store locations within the United States. Oki beverages are infused with 10 milligrams of active hemp extract per bottle and come in two different formulations: iced teas and flavor-infused water, each available in four different 16-ounce flavors. Oki supplements are available in tinctures or capsules that range in doses from 600-1,800 total milligrams of active hemp extract.
  • All products contain non-GMO, natural and organic ingredients and are plant-based and vegan friendly and packaged in sleek, 100 percent recyclable glass containers.

WeedMD-Phivida Joint Venture

Phivida has partnered with WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on manufacturing, marketing and distributing cannabinoid-infused beverages. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distributing cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets. WeedMD will be the exclusive cannabis supplier and distributor for CanBev cannabis-infused beverages. Phivida will be responsible for product innovation, research and development, formulation and branding.

Strategic Agreements

Phivida has an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is recognized as the industry leader in natural/specialty retail channel trade across the U.S. Phivida’s launched OKI brand of premium CBD products is now the exclusive CBD-infused beverage and health supplements products brand represented by NSS. This establishes Phivida as the first CBD brand company to officially cross over into national mainstream distribution across the U.S., providing new access to over 2,400 retail locations in a major distribution channel market valued at over USD $4.1 billion in retail sales.

The NSS exclusive agreement provides access to a national network of retail stores across the U.S. This national network includes major retail banners such as: Whole Foods Market, Sprouts Farmers Market, National Coop Grocers, etc. The partnership also provides the opportunity to access an additional 25,000 national conventional grocery supermarkets, including Walmart, Target, Kroger, Publix and others, via Acosta’s national sales network.

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.37, up 1.87%, on 23,101 volume with 11 trades. The average volume for the last 3 months is 38,183 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.438, off by 0.45%, on 15,100 volume with 5 trades. The average volume for the last 3 months is 13,250 and the stock's 52-week low/high is $0.026/$3.508.

Recent News

chart

Generation Alpha, Inc. (GNAL)

The QualityStocks Daily Newsletter would like to spotlight Generation Alpha, Inc. (GNAL).

Generation Alpha, Inc. (GNAL) was established in 2010 as a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to both commercial and individual growers in the United States. Originally named Solis Tek Inc., the company changed its name to Generation Alpha in September 2018 and announced an increased focus on providing innovative and must-have cannabis products and services to a growing industry.

“Generation Alpha for us means ‘new beginning’” said Generation Alpha CEO Alan Lien, when the name change was announced. “It is the new wave of how people and brands connect. We are excited with the transformation of our business strategy, our progress at our Arizona facility and the additional growth opportunities our team has identified elsewhere in the cannabis industry. While we are pleased with our innovation and progress in our Solis Tek lighting and Zelda Horticulture divisions, we believe?Generation Alpha?represents our philosophy of bringing the best cannabis products and services to the market. We are confident that this shift in our business strategy will create long-term shareholder value through diversified segments in the legalized cannabis industry.”

The name change reflects the company’s strategy to leverage business opportunities in different legalized cannabis spaces, including cultivation, processing and retail facilities. As part of that focus, Generation Alpha acts as the holding entity for a collection of companies that bring products and solutions to legal retail and commercial cannabis growers while utilizing its expertise to offer safe, quality and consistent products through its cultivation, processing, and retail facilities as well as branded products in both the medical and recreational markets. Along with its strong focus on the burgeoning cannabis market, Generational Alpha remains committed to developing and providing innovative products and services in both Solis Tek Digital Lighting, its lighting division, and Zelda Horticulture, its agricultural products division.

As part of a key piece of its cannabis focus, Generation Alpha acquired a cannabis cultivation and processing facility in Phoenix, Arizona, which is scheduled to begin operation in 2019. Currently in the design and development stage, the 70,000-square-foot facility will be one of the most technologically advanced cultivation and processing facilities in Arizona, which is a hot bed of cannabis cultivation in North America. Generation Alpha management is confident about the growth and profitability this facility provides as an essential component of its forward-thinking cannabis strategy.

Additional components of this strategy include the company’s GrowPro Solutions, Inc., a nationwide cannabis cultivator and processor and a variety of Generation Alpha brands, which include the innovation, design and selling of cannabis?products such as flower, oils and accessories in the legal medical and recreational markets.

The company’s Zelda Horticulture division offers commercial-grade rolling tables, greenhouses, PH stabilizer and nutrient products, and other agricultural products for cultivators around the world. Zelda’s custom-design cultivation options means its clients can count on increased agricultural productivity and efficiency.

Generation Alpha’s Solis Tek Digital Lighting division offers an extensive line of lighting equipment and accessories, including digital ballasts, reflectors,?complete lighting systems, single- and double-ended digital lamps, controllers and other accessories.?Each product is designed to help retail and commercial growers maximize quality and achieve higher yields and maximize quality.?

Generation Alpha, Inc. (GNAL), closed the day's trading session at $0.53, up 6.00%, on 50,920 volume with 39 trades. The average volume for the last 3 months is 70,765 and the stock's 52-week low/high is $0.289/$1.74.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.